Key Takeaways
- Nutrien reported fourth quarter 2025 net earnings of $0.58 billion ($1.18 per diluted share) and adjusted EBITDA of $1.28 billion.
- Full-year 2025 net earnings were $2.30 billion with adjusted EBITDA of $6.05 billion, supported by higher fertilizer net selling prices, record upstream sales volumes, and higher Retail earnings.
- Nutrien said it generated strong free cash flow in 2025 and about $900 million in gross asset-divestiture proceeds since Q4 2024, supporting lower adjusted net debt and higher cash returns.
- The company completed the sale of its 50% equity interest in Profertil for approximately $0.6 billion and announced additional portfolio reviews for Phosphate and certain Nitrogen assets.
- Nutrien issued 2026 guidance across Retail, Potash, Nitrogen, and Phosphate, including total capital expenditures of $2.0 to $2.1 billion.
Nutrien Fourth Quarter 2025 Financial Results
Nutrien Ltd. (TSX and NYSE: NTR) reported fourth quarter 2025 net earnings of $0.58 billion, or $1.18 in diluted net earnings per share. Adjusted EBITDA for the quarter was $1.28 billion, and adjusted net earnings per share were $0.83.
Ken Seitz, Nutrien’s President and CEO, said: “2025 was a defining year for our Company, with exceptional performance across all our operating segments and a reduction in cost and capital expenditures that surpassed our targets. Alongside delivering structural free cash flow growth, we took decisive actions to optimize our portfolio, strengthen our balance sheet and increase cash returns to shareholders.”
For full-year 2025, Nutrien reported net earnings of $2.30 billion and adjusted EBITDA of $6.05 billion. The company attributed the year-over-year increase in adjusted EBITDA to higher fertilizer net selling prices, record upstream fertilizer sales volumes, and higher Retail earnings.
4 Comments